Table 2. Results of antimicrobial sensitivity test on 16 ESBL-producing E. coli isolates against 10 antibiotics.
| Disc antibiotics | Resistance | Intermediate | Sensitive |
|---|---|---|---|
| Ampicillin (AMP 10 µg) | 16/16 (100%) | 0/16 (0%) | 0/16 (0%) |
| Sulfamethoxazole (SXT 25 µg) | 16/16 (100%) | 0/16 (0%) | 0/16 (0%) |
| Ceftriaxone (CRO 30 µg) | 13/16 (81.25%) | 2/16 (12.5%) | 1/16 (6.25%) |
| Gentamicin (CN 10 µg) | 10/16 (62.5%) | 0/16 (0%) | 6/16 (37.5%) |
| Tetracycline (TE 30 µg) | 10/16 (62.5%) | 0/16 (0%) | 6/16 (37.5%) |
| Amoxycillin (AMC 30 µg) | 3/16 (18.75%) | 2/16 (12.5%) | 11/16 (68.75%) |
| Cefoxitin (FOX 30 µg) | 3/16 (18.75%) | 2/16 (12.5%) | 11/16 (68.75%) |
| Ceftazidime (CAZ 30 µg) | 2/16 (12.5%) | 6/16 (37.5%) | 8/16 (50%) |
| Ciprofloxacin (CIP 5 µg) | 1/16 (6.25%) | 2/16 (12.5%) | 13/16 (81.25%) |
| Chloramphenicol (C 30 µg) | 0/16 (0%) | 0/16 (0%) | 16/16 (100%) |